✦ LIBER ✦

P-112 Response to azacitidine is independent of TP53 mutations in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia

✍ Scribed by Mueller-Thomas, C.; Rudelius, M.; Wolf, P.; Schanz, J.; Schmidt, B.; Platzbecker, U.; Germing, U.; Peschel, C.; Goetze, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic value of TP53 gene mutations

✍ Bally, Cecile; Adès, Lionel; Renneville, Aline; Sebert, Marie; Eclache, Virginie 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 565 KB

Incidence of 17p deletions and TP53 muta

✍ Amel Sebaa; Lionel Ades; Fanny Baran-Marzack; Marie-Joelle Mozziconacci; Dominiq 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Impact of TET2 mutations on response rat

✍ Itzykson, R; Kosmider, O; Cluzeau, T; Mansat-De Mas, V; Dreyfus, F; Beyne-Rauzy, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 268 KB

Absence of aberrant myeloid progenitors

✍ Alhan, Canan; Westers, Theresia M.; van der Helm, Lieke H.; Eeltink, Corien; Hul 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB